Work

Abstract RF4-05: PIK3R1 (p85α) alterations define a targetable subset of breast cancer with broad sensitivity to PI3K and AKT inhibitors

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-rf4-05

Authors: S. Fernando, S. Sisoudiya, I. Barlow-Busch, J. Tao, M. Fine, M. Cohen, S. Sivakumar, E. Sokol, J. Burke, N. Vasan

Institutions: NYU Langone’s Laura and Isaac Perlmutter Cancer Center, Foundation Medicine (United States), University of Victoria, Columbia University Irving Medical Center, Herbert Irving Comprehensive Cancer Center

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129611244

Cites:

Cited by:

Related to: